Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice

Authors

Kelsey L Krus, Washington University School of Medicine in St. Louis
Ana Morales Benitez, Washington University School of Medicine in St. Louis
Amy Strickland, Washington University School of Medicine in St. Louis
Jeffrey Milbrandt, Washington University School of Medicine in St. Louis
A Joseph Bloom, Washington University School of Medicine in St. Louis
Aaron DiAntonio, Washington University School of Medicine in St. Louis

Journal

Experimental Neurology

Publication Date

2-1-2025

Volume

384

First Page

115068

Document Type

Open Access Publication

DOI

10.1016/j.expneurol.2024.115068

Rights and Permissions

Krus KL, Benitez AM, Strickland A, Milbrandt J, Bloom AJ, DiAntonio A. Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice. Exp Neurol. 2025 Feb;384:115068. doi: 10.1016/j.expneurol.2024.115068. © 2024 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/bync/4.0/).

Recommended Citation

Krus, Kelsey L; Benitez, Ana Morales; Strickland, Amy; Milbrandt, Jeffrey; Bloom, A Joseph; and DiAntonio, Aaron, "Two cardinal features of ALS, reduced STMN2 and pathogenic TDP-43, synergize to accelerate motor decline in mice." Experimental Neurology. 384, 115068 (2025).
https://digitalcommons.wustl.edu/oa_4/5500

Department

ICTS (Institute of Clinical and Translational Sciences)